Early diagnosis key to epithelial ovarian cancer detection

Nurse Practitioner

Volumn 28, Issue 12, 2003, Pages 41-47

  Luce, Therese L ^a   Dow, Karen Hassey ^a   Holcomb, Lygia ^a  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CLASSIFICATION; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; MASS SCREENING; OVARY TUMOR; PATHOLOGY; REVIEW; RISK FACTOR;

CARCINOMA, ENDOMETRIOID; FEMALE; HUMANS; MASS SCREENING; NEOPLASM STAGING; OVARIAN NEOPLASMS; RISK FACTORS;

EID: 1442288864     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/00006205-200312000-00007     Document Type: Article

References (34)

1. American Cancer Society. Facts and figures: 2003. Atlanta: American Cancer Society.
2. Goodman M, Howe H: Descriptive epidemiology of ovarian cancer in the United States, 1992-1997. Cancer 2003;[ (Suppl)]:2615-2630.
3. Ozols R: Update on the management of ovarian cancer. The Cancer Journal 2002;[ 8(Suppl 1)]:S22-S30.
4. Chen V, Ruiz B, Killeen J, et al: Pathology and classification of ovarian tumors. Cancer 2003;[(Suppl) 97]:2631-2642.
5. Fathalla M: Incessant ovulation—a factor in ovarian neoplasia? Lancet 1971;, [ 2]:163.
6. Casagrande J, Louie E, Pike MC, et al: Incessant ovulation and ovarian cancer. Lancet 1979; [ 2]: 170-173.
7. Purdie DM, Bain CJ, Siskind V, et al: Ovulation and risk of epithelial ovarian cancer. Int J Cancer 2003; [ 104]:228-232.
8. Brekelmans CT: Risk factors and risk reduction of breast and ovarian cancer. Curr Opin Obstet Gynecol 2003; [ 15]: 63-68.
9. Whiteman DC, Siskind V, Purdie DM, et al: Timing of pregnancy and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prevent 2003;[ 12]:42-46.
10. Sutcliffe S, Phaorah P, Easton D: Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer. Int J Cancer 2000; [ 87]: 110-117.
11. Krsprzak L, Foulkes W, Shelling A: Hereditary ovarian carcinoma. Br Med J 1999; [ 318]:786-789.
12. Garg PP, Kerlikowske K, Subak L, et al: Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis. Obstet Gynecol 1998; [ 92]:472-479.
13. Rossing MA, Daling JR, Weiss NS, et al: Ovarian tumors in a cohort of infertile women. N Engl J Med 1994; [ 331]: 771-776.
14. Bosetti C, Negri E, Franceschi S, et al: Diet and ovarian cancer risk: a case-control study in Italy. Int J Cancer 2001; [ 93]:911-915.
15. Marchbanks P, Wilson H, Bastos E, et al: Cigarette smoking and epithelial ovarian cancer by histologic type. Obstet Gynecol 2003; [ 95]:255-260.
16. Kuper H, Titus-Ernstoff L, Harlow B, et al: Population based study of coffee, alcohol and tobacco use and risk of ovarian cancer. Int J Cancer 2000; [ 88]: 313-318.
17. Fairfield KM, Hankinson SE, Rosner BA, et al: Risk of ovarian carcinoma and consumption of vitamins A, C, and E and specific carotenoids: a prospective analysis. Cancer 2001; [ 92]:2318-2326.
18. National Guidelines Clearinghouse 2001. Screening for Ovarian Cancer.
19. Jacobs I, Skates S, Davies A, et al: Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study. Br Med J 1996; [ 313]:1355-1358.
20. van Nagell J, DePriest P, Reedy M, et al: The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecologic Oncology 2000; [ 77]:350-356.
21. Jacobs IJ, Skates SJ, MacDonald N, et al: Screening for ovarian cancer: a pilot randomized controlled trial. Lancet 1999; [ 353]:1207-1210.
22. Brown DL, Doubilet PM, Miller FH, et al: Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features. Radiology 1998;, [ 208]:103-110.
23. American College of Obstetricians and Gynecologists. ACOG Committee Opinion: number 280, December 2002. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. Obstet Gynecol 2002; 100(6):1413-1416.
24. Menon U, Jacobs IJ: Ovarian cancer screening in the general population: current status. Int J Gynecol Cancer 2001; [ 11(Suppl 1)]:3-6.
25. Gohagan JK, Prorok PC, Hayes RB, et al: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Controlled Clinical Trials 2002, [ 21(6 Suppl)]:251S-272S.
26. Hensley ML, Robson ME, Kauff ND, et al: Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life. Gynecol Oncol, 2003; [ 89(3)]:440-446.
27. Olson SH, Mignone L, Nakraseive C, et al: Symptoms of ovarian cancer. Obstet Gynecol 2001;[ 98]:212-17.
28. Conversations! 2001.
29. Goff B, Mandel L, Muntz H, et al: Ovarian carcinoma diagnosis. Cancer 2000;[ 89]:2068-2075.
30. Kirwan J, Tincello D, Herod J, et al: Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit. Br Med J 2002; [ 324]:148-151.
31. Verheijen R, von Mensdorff-Pouilly S, van Kamp G, et al: CA-125: fundamental and clinical aspects. Cancer Biol 1999; [ 9]: 117-124.
32. Meiser B, Butow P, Barratt A, et al: Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. Gynecol Oncol 1999; [ 75]: 122-129.
33. Narod SA, Risch H, Moslehi R, et al: Oral contraceptives and the risk of hereditary ovarian cancer. N Engl J Med 1998; [ 339]:424-428.
34. Alliance Action. (2000). Ovarian cancer national alliance overcoming together, 3(2). [Brochure]. Washington, DC:Alliance Action.